Urothelial cancer

Description: 
Available test Fluorescence in situ hybridisation analysis of ThinPrep slides using the UroVysion FISH assay
Clinical details: 
The Urovysion FISH assay is intended for use in conjunction with current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients with hematuria and subsequent monitoring for tumor recurrence in patients previously diagnosed with bladder cancer.
Synonyms or keywords: 
UroVysion, urothelial cancer, bladder cancer, transitional cell carcinoma, TCC
Department: 
Sample type and Volume required: 
ThinPrep slide from urine sample
Turnaround time: 
Current service turnaround times: Urgent 2-7 calendar days; Non-urgent 5-10 calendar days; National targets: Urgent samples 95% reported within 14 days; Non-urgent 95% reprted within 21 days
Contacts:
Oncology Cytogenetics Laboratory at Guy's Hospital
Genetics Department
Tower Wing - 5th Floor
Guy's Hospital
Great Maze Pond
London SE1 9RT

T: 020 7188 1715
For clinical advice or interpretation of results, please contact the laboratory in the first instance.

Print as a PDF

Last updated: 07/08/2015